Jul 23, 2024 8:00am EDT 180 Life Sciences Granted an Additional Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements
Jul 02, 2024 8:30am EDT 180 Life Sciences Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements
Mar 14, 2024 8:30am EDT 180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
Feb 26, 2024 7:00am EST 180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance Plan